Skip to main content
MedPathMedPath Home
Clinical Trials/KCT0009294
KCT0009294
Not yet recruiting
未知

A preliminary study to evaluate patient outcomes, feasibility, preliminary effectiveness, safety and economic evaluation of Korean medicine treatment for periodontal disease

Dongguk University Ilsan Oriental Hospital0 sites45 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dongguk University Ilsan Oriental Hospital
Enrollment
45
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Dongguk University Ilsan Oriental Hospital

Eligibility Criteria

Inclusion Criteria

  • •(1\) Individuals aged 20 years and above but below 65 years, regardless of gender.
  • •(2\) Those diagnosed with gingivitis and mild periodontitis.
  • •(3\) Individuals who voluntarily provided written consent to this human application trial through the Informed Consent Form.

Exclusion Criteria

  • •(1\) Patients with severe or advanced periodontitis.
  • •(2\) Individuals who have undergone scaling and preventive periodontal treatment within the last 3 months from the date of consent form completion.
  • •(3\) Smokers.
  • •(4\) Individuals with orthodontic appliances.
  • •(5\) Those with pathological findings in the oral tissues or requiring treatment from other departments.
  • •(6\) Individuals requiring immediate treatment for dental caries.
  • •(7\) Individuals with uncontrolled chronic conditions such as diabetes, liver disease, heart disease, kidney disease, bleeding disorders, or other chronic illnesses.
  • •(8\) Those with clinically significant immune, infectious, neoplastic, or psychiatric disorders requiring treatment.
  • •(9\) Users of medications that may affect periodontal health (nifedipine, phenytoin, cyclosporine).
  • •(10\) Those who have taken antibiotics within the last 4 weeks, are currently taking antibiotics, or are planning to receive antibiotics in the future.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Prospective study to evaluate the clinical outcome of POEM combined with endoscopic anti-reflux surgery.
JPRN-UMIN000028567Showa University Koto Toyosu Hospital100
Recruiting
Not Applicable
A prospective assessment of patient outcomes following joint replacement surgeryKnee ArthritisHip ArthritisMusculoskeletal - OsteoarthritisMusculoskeletal - Other muscular and skeletal disordersSurgery - Other surgery
ACTRN12618000317291A/Prof John Ireland3,000
Recruiting
Not Applicable
A study evaluating the effect of iTBS in patient with treatment resistant depressio
CTRI/2019/04/018367All India Institute of Medical Sciences New Delhi
Recruiting
Phase 1
The efficacy assessment of 225Ac-PSMA-617 in Prostate cancer treatment.
IRCT20211206053304N2Iran University of Medical Sciences10
Active, not recruiting
Phase 1
A Study of RoActemra/Actemra (tocilizumab) in Comparison to Enbrel (etanercept) in Patients With Rheumatoid Arthritis and Increased Risk for Heart Disease.Rheumatoid ArthritisMedDRA version: 14.0Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
EUCTR2010-020065-24-ESF. Hoffmann-La Roche Ltd.2,800